
UK AgriBioTech startup Resurrect Bio closes €8.8 million Series A to develop disease-resistant crops
Resurrect Bio, a London-based agricultural BioTech startup developing disease-resistant crops, has closed its oversubscribed Series A funding round at €8.8 million ($10.3 million). In February 2026










